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The anti-tumor action of many chenlOtherapeutic 
agents has recently been attributed to the induction 
of apoptosis in the malignant cell population. In this 
study, we investigated the ability of extra corporeal 
photopheresis (ExP) and ill "UI'O PUV A (8-methoxy-
psoralen + ultraviolet A) therapy to induce apoptosis 
in peripheral blood lnononuclear cells [roln Sezary 
syndrome patients and norlnal controls. Flow cyto-
metric analysis of ExP- or PUV A-treated peripheral 
blood lymphocytes demonstrated two distinct cell 
populations within 24 h of treatment. One population 
was sitnilar to untreated controls with the other 
exhibiting characteristics of apoptotic cell death, i.e., 
a loss of cell volulue and an accolupanying increase in 
cell density. This latter population was comprised of 
cells with DNA strand breaks as determined by the 
Tdt-mediated deoxyuridine triphosphate-biotin nick 
end labeling assay. Apoptosis was also confirmed 
rnorphologically by fluorescent and electron micros-
copy as well as by demonstration of characteristic 
A poptosis is an active fi,'l)rm of cdl death charact.erized by lIlorphologi c and biochelllic;d ch anges very dif-ferent fi'olll necroti c ce ll death (Cohen, 1993; Ke rr ('I n/, 1994) . Apoptosis has been demon strated to pla y an impo rtant role in elllbryon ic developmcnt (Gold-
man el n/, '1983), in the gener~tion ~nd maintenance of rhe immune 
system (Cohen. 199 1; Co hen and Duke, 1992), in T-ce ll lym-
phoma (CTL)-mediated iml11ulle reactiom (Cohen and Duke . 
1992), and in the normal ClIrtlover of ditl:c re ntiated cells (Martin 
and Johnson. 19\1 I). A growing body of ev id ence also indicates that 
the action of various anti-tumor agents. including irradiation 
(Sellins and Coh e n , 1987), horlllonal therapy (R.eddillg ci al. 1992), 
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DNA strand breaks (laddering) using gel electro-
phoresis. Apoptosis was not observed with 8-me-
thoxypsoralen (~300 ng per ml) alone; however. ul-
traviolet A alone at doses 2:: 2 J per cm2 induced 
apoptosis in lymphocytes. Peripheral blood T-cell 
subpopulations of Sezary syndrome patients, includ-
ing the malignant clone. were equally susceptible to 
apoptosis subsequent to either photopheresis or 
PUVA treatment. In contrast, monocytes (CD14+1 
CD45+) appear to be resistant to apoptosis induction 
by ExP or PUV A treatnlent. Moreover, ExP-treated 
and untreated luonocytes phagocytized apoptotic. 
but not untreated, peripheral blood mononuclear 
cells. ExP and PUV A have been shown to be effica-
cious and well-tolerated therapies in the treatment of 
derillatologic diseases and transplant rejection. 
These data suggest that induction of apoptosis may 
be an important event for therapeutic efficacy. Key 
"'OI'ds: Seza I'}' sJI1IdvomelpsoJtalel/lextJ'acOI7'ol'ea I p/Jotop/JeJ"e-
sis. ] 1I1J1est Del'matol 107:235-242, 1996 
and cytotoxic chemotherapy (Gorczyca el nl. 1993a. 1993b) may in 
fact be efl'icacioLls b y in ducing apoptosis in the malignant cell 
population (Dive and Hickman, 1991; Hickman. 1992; Kerr ('( n/, 
1\194). 
A uniquc type of ami-tumor therapy is photochemotherapy 
(I' T). Two types of PCT, both of which employ the DNA 
intcrca latOl·. 8-methoxypsora len (8-MOP), and long wavelength 
ultrnvi o let radiation (320-400 nm , UV A), arc llsed in the treat-
m ent of cutaneous T-cell lymjlho11l<l (CTCL) and its leuke11l1c 
varianr. Sezary syndrome, which is characterized by erythroderma 
and c ircul ati ng malignant atypica l lymphocytes (Sezary ce lls) in the 
skin and peripheral blood (Edelson, 1980; Wieselthier and Koh, 
1990). 
Psoralcn in combination with UV A (PUV A) is lIsed to treat early 
stage CTCL (Gil chrest cl nl, 1976: Gilchrest, 1979; Roenigk. 1979; 
Honigsmann 1'1 n/, 1984) wherea s e xtracorporea l photopheres is 
(Ex P) therapy is used in the tre<1tmenr of jlatients with Senry 
syndrome (Ede lson (., n/, '1987; R.ook ('( n/. 1992). PCT has also been 
used successfull y for the treatmcnt of psoriasis (Parrish el n/. 1974). 
systemic sclerosis (Rook 1'1 n/, .1992), acute transplant rejection 
(Costanzo-Nord in el n/, 1992), and other T-cell-mediatcd diseases 
(R.ook CI n/. 1993) . Although PCT has been lIsed clin ica ll y for mallY 
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yea rs, vel-y little data c urren tly ex ist I-egardin g the me ch anisms by 
whic h th is th erapy is e ffective_ 
Severa l different lines of eviden ce indicate that ExP resul ts in 
apoptotic cell death_ Pre vio u s studies ha ve d e monstrated that 
psora lens, including 8-MOP, intereal a t.e .inro double-stranded nu-
cle ic acids and bind to p yrimidin e bases (So n g and Tapley, 1979). 
Upo n exposu re to UV A li g h t, photo-addition occu rs w ith th e 
formation of monoadduc ts and covale n t c rosslin ks of the DNA 
(Gaspa rro, 1994). Foll owing H-MOP + UVA t reatment, lympho-
cytes a re unable to pro li fe rate as e vide n ced by re duced incorpora-
tion of rJ H)thym idine into nu c lea r DNA in un stimulated and 
mitoge n-stimul ated lymphocytes; h owever, assessm e nt of cell 
membrane integrity, as dete rmined by trypan b lue dye exclusion, 
indi cates that th e m e mbrane remains intact. These cell s, h owever, 
eventually die over a p e riod of about 72 h (Song and Tapley, 1979; 
W arwick ci aI, 1981; Gasparro cl aI , 1989) . A previou s study by 
Marks rI al indi cated th at tre atment of periphera l blood m o n onu-
c1em- cell s (P13M C) w ith Ex P resul ted in an inc rease in DNA sing le 
stnl11d breaks w ith a conco mitant dec rease in c e ll u la r ATP and 
NAD; th is d amage th en leads to cell death (Marks el aI, 1990) . In 
subsequ ent studi es, th ey d emonstrate th at periphera l b lood lym -
phocytes (PBL) as well as a T-cell line (CEM) und e rgo apoptosis ;IS 
a I-esult of PUV A tre atment; h owever , th e doses of UV A utilized in 
th ese exp erime n ts were approx imate ly five t imes th o se u sed in Ex !> 
(Ma rks and Fox , 1 <)<)1) . 
In thi s study, we investigated th e ab ili ty of ExP a nd ill lIilro PUV A 
the rapy to indu ce apoptosis in CTCL alld 1I 0rmal patient PBMC. 
PCT-treated ,md untreated cell s we re examined by seve ral meth-
ods, in cluding Row cytometry, tluoresccn ce m icroscopy, e lectroll 
mi croscopy , and DNA gel elec troph oresis for th e character istic 
morphologic and b ioch em ical features of apoptosis. We a lso ex-
amin ed the kinetics and effects ofPCT 0 11 specific subpopu lation s of 
PI3MC, in c lu di n g p e riphera l b lood T-cel l subpopul ations_ 
MATER.IALS AND METHODS 
Reagents COl11plete media consisted of R_PM I 1640 medium sup ple-
mented with 10'X, heat-inactivated few I bovine se rum. 2 mM L-I;lu tamine, 
100 I U penicillin per ml , and 100 JLg strepton l),cjn per 1111 (Life Techno lo-
gies, Inc .. Grand Island , NY). 8-MOP (S igma C hemica l Co ., St. Lo uis. 
MO) stock so lution in abso lu te ethano l ( 100 JLg pe r ml) was stored at 
- 200C in the dark fo r no longer than u mo. All flu orochrome-labeled 
antibodies (CD4-PE, C D7-FIT C, CD~-F I TC , C D45-FITCIC D14- PE, and 
mo use IgG ,FITC/mo use IgG, YE isotypc con tro l) were obtained from 
DAKO (Santa Barbara , C Al 
Patients Patients participa ti ng in thi s study were di<1 gnosed with CT L 
(Sezary syndrome, n = 9) as ddined by cl inica l and laborato ry fIndings (Sen 
and D' incalci, 1992) . Donations of hlood by patients or normal vo lun teer, 
ill th is study confo rnl c d to in stitutio nal re view board-approve d protoco ls. 
and informed consent was obta ined. 
[solation ofPBMC Venous blood was collected in heparin rr0111 normal 
volun teers and fr0111 CTC L patients iml11ediatdy prior to Ex P. Post-Ex P 
blood was removed directl y frolll the photopheres is unit upon conclusion of 
treatment immediately prior to inliJsion into the patient. The blood WaS 
d ilu ted 1:2 with pho.,ph" tc-buHcred sa lin c (PBS) and layercd on " Ficoll -
H ypaque gradient (Plllll-macia Biotech, Pi tscataway, NJ). T he gr:ld ient was 
ccnttifuI;ed for l 5 Illin at 2200 rpm at room temperature . and the PUMC 
layer was co ll ected and washed X 2 ill PBS. T he cel ls were resuspended in 
complete media . 
l lf Vitro PUV A Treatment PBM C in comp lete 11Ied i;1 (10" ce lls pe r 1111) 
were incuba ted with various co ncentratioll s of H-MOP (0-300 ng per ml) 
for at least 15 min and then exposed to diHerent doses of UVA light (0-3 J 
pcr CIII ·'). Ce ll suspens ions were irradia ted in ce ll cul ture cluster d ishes 
(Costar Corp., C ambridge, MA) with a UVA light box (Therakos, West 
C hester , PAl containillg a seri es of lIine UVA bulbs (emission speclTa of 
320-4()0 nm. peak at 352 nm) ill the top and the hottom banks separated by 
two glass plates. An IL700A research radiolllete r (In ternational Light. 
Newbu ry Port, MA) was used to calibrate the UVA light box, which 
em itted he tween 10. 14 and l 1.7 1 m W per cm' when corrected for passage 
thro ugh the polystyre ne plate . T he emission spectra, peak wavelength of 
emission , and total aver;l ~e jo ules per cell volullle delivered were identi ca l 
to those util ized in th e photopltcrcsis instruill c ii t . The tfeated and ull trea ted 
contro l samples were subsequently incubated at 37°C in a humidified 
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atmosphere of 5% CO2 for d illcrent periods o f ti llle Il l' to 48 h fo llowing 
UV A exposure and thell assessed for apoptosis. 
Extracorporcal Photocltemotltcrapy Patien ts were treated usillg the 
ultra violer A radiation (UVA) photol'heresis syste lll (Therakos) as previ-
o usly desc ribed (Edelson rl 01, 1 \)~7 ; R ook rl "I, J \)92) . Uri" fl y, Ex P involves 
the ill gestion o f 8-MOP (0 .6 IlIg pe r kg) ill o rder to achieve therapeutic 
plasma leve ls (> 50-100 II I; p C I' 1111). Two hours after ingestion of the 
psora len, the patient undergoes a discontinuous Ic ll kop heresis procedure 
with exposure of removed leukocytes to UV A. During the procedure. 
approx imately 240 1111 of leukocyte-enriched b lood arc mixed with 3UO 1111 
of the patient's plasma and 200 1111 of steril e saline with heparin . This resulc 
ill appro)(imate ly 15% of the patient' s circulating le ll kocytes " " illg created 
during the photopheres is process (Lee and Garro, · 1 9~9). The blllFy coat is 
then passed as a 1-111111 film through a steri le cassettc surro unded by 
UV A-emitting hulbs (320-400 11111), permitting 1 HO-Ill in ex posure of the 
ce ll s to UVA, and yie lding an ave rage exposure per lymphocyte of 2 J pcr 
cm'- T he treated buffy coat is then retu rned to the patient. 
F low Cytometric Analysis To assess apopros is by How cyl:OJll etry using 
ligh t sca tte r mcasurelllents, pre-, and post- PCT -treated ce ll samples (1 0" 
cells per 1111) at variou s in c uba tio n tinles were fixed ill 2tXt paraforlnaldc-
hyde, pH 7.4. Forward and side light scaner we re ana lyzed at a ce ll flow ra te 
of 500 ce ll s per sec using a FACScall Flow Cytollleter (Becton Dicki nson. 
San J ose, C Al . To identify the difrer"nt ce ll t)'pes, surfi,cc antigellS of hullIan 
PBM C were sta illed with Auorochrome- Iabded antibodies (C D4-PE/ CD7-
FIT C , CDS-FITC o r CD4 5-FIT CIC D 14-PE) by incubating 10" cells ill 100 
~t1 of PI3S with 10 ,.1.1 of anribody for 30 min in an icc bath. T he ce ll s wcre 
washed with PBS and resuspended in 0.5 ml of 2% paraforl1la ldeh yde , pH 
7.4 . MO llse IgG , FITC/mouse IgG, yE was uscd for dercrm ination of 
background staining. Flow cytometry was perfo rmed usin I; the Becton 
Dicki nson FAC Scan Flow Cytometer equipped with all argo n laser for 
l1uorescein iso thiocyallate (F ITC) (4H~ IlIn) and phycoerythrill (480-550 
11m) excitation. Gn.:en and red fluo rescence o f individual cell s using 
logarithnlic anlp lifi cation "vere lll c asu rcd. The data frOtH 'I rrl events per 
saJIIlle were collected and ana lyzed using L YSYS II software . 
III S itu Termin al DeoxYllltcleotidyl Transferase (Tdt) Assay Tdt-
mediated dUTI'-biotin nick elld labeling (TUNEL) assay of DNA fragmen-
tatio ll as previously described by Sgonc ('I 01 (Sgonc "I "I, 1994) was adapted 
for usc with fi ow cytollletry. Brieny, 1-2 X 10" cell s we re fixed in 2% 
parafonrlJ ldchyde for 30 min at ro0 1l1 te l1lperature a ll a horizoll ta l shake r. 
washed ill PBS and then permeabi lized with 0 .1% Triton Xl00/0.l % 
sodium citrate . The cells were then incubated in a humidified challlber (1 h_ 
37"C) with 0 .3 nnwl of F1T C-1 2-dUTP (Boehrin ge r Mannheim Biochemi-
cals, Indianapo li s, IN), 3 11111 of dcox yadellosinc triphosphate, 25 U ofTdt 
(Promega Corp., Madisoll, W I), and Tdt buHcr ( I 111M CoClo. w O m M 
cacodylate buller. pl-l 6.H, O. I mM dithinthreito l) ill a tOtal reaction volume 
0[50 JLI. T he reaction was stopped by adding 2 JLI ofO.S M ethylenediamjne 
terraacetic acid (EDTA). After washing tw ice with PUS, the 5<l1l1l'l es Were 
allalyzed with ill 6 h USill I; FACSca n with 'Ill argo n lase r (48H nlll) . The data 
from I lr' eve llts per samph! were co llected and sto red usillg L YSYS II 
software. 
DNA Extraction and Agarose Gel E lectrophoresis A bOUl 5-10 
·10" ce ll s in media were collected by centrifllgation, washed ill PUS, and thell 
resuspended in 1 ml of freshl y made lysis butte r conrailling ·100 rnM NaCI, 
50 mM EDTA, pl-l 8. 0, 0.1% sodiun! dodecyl sulfate, and 0. 1 mg Proteinase 
K per ml (Fisher Sciellti fic, Fa ir Lawn , NJ). Salllpi es were incubated 
overni ght at 37°C with gentle rocking. T he DNA was then extracted with 
an equa l volume of phcno l:chloroforl1l:i soarn)d alcoho l solution (25 :24: 1) 
and precipitated with 3 M sodium ace tate. pH 5.2 , " nd ·100% icc-cold 
ethanol. T he DNA precipitates were washed twice in 70% ethano l, dried by 
Speedvac evapora to r, alld resu spended in TE buffer (10 mM Tris-HC I. 1 
mM EDTA), pH 8.0, overnight at room tem perature. T he DNA w as 
q uantified by UV absorballce at 260 ;lIld 2~0 11 m. About 10-·15 JLg of DNA 
were added to each we ll. and ho rizo ll ta l c1ec trophon:sis of DNA "', 
performed for 2 h at 75 V 0 11 2% agarase gel. Th" rUl1n ing bulle r contained 
90 mM Tris(hydroxYlllethyl)-aminoethane, 90 111M bo ri c acid , alld 2 111M 
EDTA. pH H.O . DNA was sta ined with ctltid iurll bromide and visualized 
under UV Li gh t. 
Quantification of Apoptotie Cells by Fluorescence Microscopy 
ASSCSS I11 CIlt of apoptosis by AuorCSccllt 1l1i c roscopy was donc lIs in g prc,-i- I 
ously described methods (D uke and Cohen. 1992). Briefly. a 4-JLI aliquot of 
dye l1Ii xture consistin g of 100 JLg acridine o rallge pcr ml and 1 00 p.~ \ 
ethidium bromide per ml in PBS was added to 100 JLI of ce ll slI spcll si II 
( IO"ce li s per ml) alld mixed gemly. A 25-JLI aliquot o f tile stained cell s \\' a; 
then placed On a slide, coverslipped. and viewed on n flu o rescen t micro-
scope using cpi-i llumination and a fi lter cO lnb ill atio ll sui tab le for o bserving 
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Figure L Flow cytometric analysis of apoptosis following peT of Sezary Syudronle patient. Pallds a and .. show forward 1'1'1''<11" side light scatter 
prior to and 24 h after PCT_ respective ly. T he shi ft to the R2 ga te is indicative of nuclear condensation and decreased cell size. b and d) Binding o r 
fluo rescein-labeled dUTP to 3'-end orO NA (TU NEL assay) prior to and 24 h after PCT. respectivel y_ T he increase in binding observed at 24 h in the R.2 
gate indicates increased DNA fi·agl1lentation. 
fluorescein . Apoptotic ce lls were determined based O il cell size. nuclear 
condensation. and fill orescence. A ll1inimum of 2()O total ce ll s wcre 
cxan1.incd. 
Electron Microscopy PBM C were fixed as pe llets in 2')1" glurara ldehyck 
in 0. 1 M cacodylate bulle r. pH 7.4. overnight at 4°C and subsequently 
post-fixed with 1 %1 OSIlliuI11 tetroxide in t il t.! sa ill e bucrer fo r 1 h at 1'00111 
temperatu re. Afte r washing, the cell pellets were dehydrated throngh 
g raded alcoho ls to abso lute ethanol :md then propylene oxide. Embedding 
was done ll sing Taab 8 12 epoxy resin (Mariv"c. Ltd .. Hali t,,,, , Nova Scotia) 
iJl BEEM capsules (13ron". NY). T hill sec tions were cut on an LKI3 
U ltratome III (LKB InstrunH:llts, R.ockvill e. MO) post-stained with alco-
holi c uranyl acetate and bisllluth subnitra te. and viewed with " Hi tachi 7000 
electron microscope. Apoptotic cell s were identified morphologically as 
dc tcrnlincd by conde ll sation of nu clc;lr chro lllHtil1. decrease ill ce ll si ze. allo 
ce Ll-surface b!ebbing. For quantification. a minimum of 200 ce lls were 
e va luated. 
Phagocytosis Assay To obw in monocyte-derived ma crophages. 1 mlof 
u ntreated or Ex P and PUVA-treatcd PI3M C ce ll suspension in complete 
media (10" ce ll s per ml) was added to a 24-well polystyrene ti ssue culture 
p late (Corlling, Corning. NY). After GO-min incubation at 37"C. the 
nonadherent cells were removed. T he plate was washed three times with 
PBS. and 1 1111 of fresh complete med ia was added. T he cul tl11'cs were then 
incubated at 37°C and 5''1., CO, fo r 4-5 days. O ne millilite r of untreated or 
ExP- and PUVA-n'eatcd PI3M C at O.S-I .O X 10" ce ll s per 1111 was then 
added to the monocyte cul tures. C ultures were incuba ted for I h at 37°C . 
5% CO2 , T he wells were washed twice with warlll PI3S to relllove 
nonadhcrc ll r ce ll s alld th e ll sta in ed w ith WI~ibht ' s stai ll . 
RESULTS 
A poptosis of ExP and PUVA-Treated PBMC Is Demon-
strated by Flow Cytometry Normal and patient (CTC L) 
PE M C were e ith e r treated w ith E"P or ill IIifm PUVA th e rap y usin g 
doses of 8-M O P and UV A similar to those routinely used clinically 
in ExP (100-200 ng 8-M OP per ml + 2 J UVA pel- cm 2). T he 
treated and untreated cells were th en eX~ l11ill ed b y fl ow cytom etry_ 
T he ch~racteristi c chan ges in th e 111 0 rph o logy of ce lls undergo in g 
apoptosis, includin g cell shrinkage and nuclea r condensatio n_ affect 
the ce llul a r lig ht scattering pro perties as detected by flow cyto m-
erry. Sevcral in vestigators ha ve o bserved that cell s undergoin g 
apoptosis have a d ecrease in fo rw ard light sC;ltter (FSC) and 
increase in side light scatter (SSC). in di cating a loss of ce ll vo lume 
w ith an accompan ying in crease in ce ll density (Swat CI ti l, 199 1; 
Darzyn kiewicz 1'1 ti l, 1992; Dive c'1 ti l, 1992; Z amai ,,' ti l. 199:1; 
H uschtscha cl ti l, 1994 ). In o rder to assess apo ptos is in nOl'l1wl 
human PBM C treated w ith E" P o r PUVA. we exa mined changes in 
the ir li ght sca tte r m e:lsurements. By 2-1- h post-Ex!' o r PUVA 
treatm ent , there wel'e two distinct cell populations (Fig la and c). 
O n e po pulati on was silllilar to un treated con tro ls and the second . 
c omprised of 2: 50')1" of the tota l cells. had a dec reased FSC and 
increased SC, characteristi c of light SG1tter changes in apoptotic 
ce ll s_ In orde r to ;Issess w hethe r the PCT-treated cel ls were 
undergoin g the characte ri stic in ternucleosomal DNA fragm ent:1-
tio ll ofapoptosis (Sgon c CI til, \ 994), an adaptation of the TUNEL 
assay for flow cyro m etry was used to detect DNA stI-and breaks. 
Th is aSS:1y demonstrated th at the tre:1ted cells in corporated much 
more FITC-dUT!' when com pared to t he untreated controls. 
Gati ng on the shifted po pulation (R.2) with low FSC/ high SSC 
showed that these ce lls stained more bri ghtly with FITC-dUTP 
th an the nonshifted population (R 1) (Fig 1/, and d) dcm o nstrating 
tllil t the R 2 population al-e indeed apoprotic ce lls. 
ExP AND PUVA Cause DNA Fragmentation Consistent 
with Apoptotic Cell Death Do ub le-stranded DNA ITagmen-
tation at the lin ke r regions betwecn nll cleosom cs as part of the 
apoptotic proccss leads to the fo rm ation of DNA fragm ents that arc 
Illultipl es of 180-20U bp in size (Arends 1'/ til. 1990; Sell ins and 
Coh cn , 1987). ln te rnucl eosom al DNA fragme n tation was verified 
by agarose gel electrop ho resis of gen omic DNA fi-ol11 ce lls treated 
with ExP and PUVA after 24 and 48 h of incubation but not ITom 
contro l (un treated) ce ll s (data n o t shown) 
DNA-Binding Fluorescent Dyes Demonstrate Apoptotic 
Cell Death Following ExP and PUV A Furrh er co ntlnnation 
of apoptosis as the Illode of ce ll death in the PCT -treated PBM 
was obtain ed using DNA-bind ing Au orescem dyes (acri di ne o range 
and ethidiul11 bromide) alo ng with fluorescent mic roscopy_ 
Fluorescence microscopy was pertormed 24 and 48 h after 
expos ure to doses ofUVA- 8-M OP used in c lini ca l ExP_ In o rder ro 
d etermin e th e pe rcen tage of ce ll s undergoing apoptos is_ a minimulll 
of200 ce lls were exa min ed and class ified in to olle offour ca tegories 
descri bed previous ly. T he m o rphologic features of apoptosis in-
cluding ce ll shrinkage. co mpac tion of nucl ea r chro matin into 
sharpl y c ircumscl-ibed dense masses around the periphery of the 
nucle i. and cytoplasmi c condensatio n (Cohen. '1993; Kerr el til , 
1994) were a ll observed in the PBM C n-eatcd w ith ExP or PUVA 
but not in the co ntrols (Table I) . 
Table I. Comparison of Methods Used to Assess 
Apoptosis" 
Apoptosis 
A SSCSSJ11 C ll t (, h 24 h 48 " 
Method U ll t reated POSI"-PUVA" post-I'UV A pOSl-PUVA 
Flow c)'tom<:tr)' 2'(, :!: _. I 3.') :!: 2.4 (, 1.2 :!: 19.9 84.8 :!: 1.1 .2 
Fluo rescent 
tlllCroscopy 3.9 :!: 1.7 2.7 :!: 1.1 S ~7.7 :!: 8') -13 .2 :!: 9.6 
EIl'errol] Jlli c roscopy 1.2 :!: 0 .. 1 1.5 _ n.-I 24.3 :t 7.5 n.d . 
II V;l ltln L' xprcs~cd a ~ p l'fl"L'1H o(tor:11 PBM C :: SD dwt ",,,-'rt! ;Ipoptnric. A I1lini111l11ll 
o r f\)lIr ~ l1bjL'ns Wcrl.' assessed for c;Il.'h gro llp . 
/. P13fv\C were trc:llcd wil"h 200 ng B-MO P per m' :lIld "2 J nr V A IlL'r r l\\ ~. 
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Figure 2. Visualization ofapoptosi.s by electron microscopy. Venous blood was co llected from CTCL patients and treated ;/1";''''' with I'UV A. PBM C 
were iso lated and visualized by EM. Photom i cro~raphs shown are representative of three patients examined. n) PBMC prior to PUV A. No apol'totic cells 
arc observed. Note cerebriform nucle i characteristi c of Sezary cell s (scale Imr, 5 JLm) . /J) PBMC 24 h after I'UVA. Arrows indicate sever,, 1 ce ll s "t dilferent 
stages of apoptosis (scnle !J"r, 5 JLm). c) PJ3MC 24 h after PUVA . (> indicates apol'totic cel l: • indicates apoptotic 'b leb' (5mle b"r. 5 , .. un). 
Characteristic Morphological Changes of Apoptosis Occur 
Following ExP and PUV A PBMC isolated fi'OIll three CTCL 
patients were treated ;11 ,,;Im with 200 ng 8-MOP per ml and 2 J 
UV A per cm2 and examined by electron microscopy for changes 
charactcristic of apoptosis at 6 and 24 h after lJUVA treatment. 
Apoptotic cells tota led < 2'X, in untreated PBMC or at 6 h post-
PUV A treatmcnt (Table I) ; however, 24.2 ± 5.6'Yo apoptotic cells 
were observed in PBMC obtained at 24 h after PUVA (Fig 2) . 
C haracteristic nuclear condensation as well as blebbing of the 
cytoplasm were observed in all thrce samples examined. 
Kinetics of Apoptosis Induction Are Similar for Both ExP 
and PUV A Treatment To dctcrminc the kinetics and time 
necessary to detect apoptotic ce tts following ExP, PBL obtained 
fi'om the treatment device immediately prior to rein fusion into the 
patient were examined by Row cytom etry at 6, 24, and 48 h 
following treatment using light scattering properties . Only th e live 
and apoptotic lymphocytes were gated in order to e liminate all 
debris. No apoptotic ceUs were detected 6 h after treatment when 
compared to patient-matched unlTcated PBL; howcver, 24 h after 
treatment > 50% of the cells were apoptotic. By 48 h after 
treatment, approximately BO-90% of the cells were apoptotic (Fig 
3a). Simi lar resu lts were obtaincd for PBL treated ill "ilm with 
100-200 ng 8-MOP per ml with subsequent exposure to 2 J UVA 
per cm2 , the same condition s uscd in ExP (Fig 3b). 
Psoralen Concentration and UVA Dose Correlate with the 
Induction of Apoptosis Preliminary studics indicated that vari-
ations in the concentration of 8-MOP or dosc of UVA affected the 
percentage of ccll s that becmne apoptotic. To dctermine the 
minimum cffective dose of UV A that was necessary to induce 
apoptosis in human PBL in the presence of various concentrations 
of8-MOP, a scries of experimcnts using a checkerboard titration of 
UVA (0-3.0 J per cm2 ) verslls 8-MOP (0-300 ng per ml) werc 
performed. 
At 6 h post-treatment, no apoptotic cclls were ev idcnt at all UVA 
doses or 8-MOP concentration s (Fig 4a); however. by 12 h , 
apoptotic cell s wcrc present in the PBL treated with 2.0 and 3.0 J 
UVA per cm 2 at all con centra tions of 8-MOP, including no 
8-MOP, suggesting that the UVA alon e W;IS induc ing <tpoptosis 
(Fig 4/,). 
After 24 h, the population of apoptoric cclls present in PBL 
trcated with 2.0 and 3.0 J UV A per Cl11 2 had doublcd (frol11 25% to 
50%) at concentrations of 0 and 25 ng 8-MOP per ml. whereas the 
number of apoptotic cells in the PBL treated with 5()-300 ng 
8-MOP per 1111 at the same dosage of UV A triplcd (fi'OI11 25% to 
75%). PBL treated with 1.0 J UVA per cm 2 had :tn increased 
apoptotic population whcn 8-MOP conccntration was 2: 50 ng per 
1111. No apoptotic changes abo ve baseline were observed in PBL 
trcated with 0.5 J UVA per cm:! at all con centration of8-MOP (Fig 
4c) . 
At 48 h post-treatment, nea rly all ce lls treated with 2.U or 3.0 J 
UV A pcr cm 2 and 2: 50 ng 8-MOP per ml were apoptotic. A 
significant number of cells (> %50) treated with 0 o r 25 ng 8-MOP 
per ml and 2 .0 or 3 .0 J UVA per Cl11 2 were also apoptotic. Celli 
treated with 1.0 J UVA per cm 2 and 2: 25 n g 8-MOP per ml also 
had an increased percentage of apoptotic cell s (Fig 4d). 
To dctermin e whether there was correlatio n between the percent 
of apoptotic ce ll s and thc dose ofUVA X I. B-MOP] used to treat the 
ccll s, linear regression analysis was pcrformed on data co ll ected at 
48 h post-treatment. This analysis revea led ;1 highly significant 
correlation (r = 0.90) for values of UV A X [8-MOP] of < 150 (e.g. 
2 J UVA per C111 2 X 50 n g 8-MOP per tnl = 100). Whcn thc value 
of UVA X [8-MOP] w~s > 150, the entire Iymphocytc population 
was apoptotic. 
ExP AND PUVA Induce Apoptosis in Lymphocyte Sub-
populations but not in Monocytes Two-color Row cytol11etry 
w~s utilized in order to identify subtypes of lymphocytes fi~ol11 
IOO .-------------------------~_, 100 
Figure 3. Kinetics of apoptotic cell appearance fol-
lowing PCT. PBL treated with ExP (A) or 8-MOP (200 
ng per ml) /UVA (2 J per cm 2 ) (B) were examined for 
"poptotic cell s by How cytometry at 6. 24, and 48 h after 
treatment. Untreated cells were obtained prior to ExP and 
cultured under the identica l conditions as the treated ce ll s. 
Dat" presented arc the mean :': SD of a minimum of six 
subjects with Seza ry Syndrome. 
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Figure 4. Effect of 8- MOP concentration and UV A dose on induction of apoptosis. A checkerboa rd titratio n of 8-MOP (0 - 300 n l; pl!r m l) and 
UV A (0 .0-3.0 J per cm ' ) was u ti li zed to detcrminc rill! minimum combinatio n neel!ssa ry to induce apoptos is. PBL we re l!,,"min d to r apoptotic changes by 
Aow cytom ctry at 6 h (n). 12 h (11).24 h (r), and 48 h (d). UVA dos"gl!: 0 (-0-). 0.5 (-0 -), 1. 0 (-0-). 2.0 (-6 -). 3.0 (-EB-). Data presented 
arc rep reselltati ve nf tha t o htailled fro lll three subj ects. 
nonnal o r patienr (CTCL) PBMC and their susceptibility to 
apoptosis subseq uen t to e ither Ex P o r PUVA treatment. In order to 
en sure that the cell s being examined were lymphocytes, simulta-
ne ous two-co lor staining with CD45-FlTCICD14-PE and li ght 
sca tter m easurem ents were used (Loken cI of. "j 990) . In norm <11 ,md 
CTCL lymphocytes, we o bserved the clwractci-istic apoptotic shift 
(decrease FSC/increase SSC) in different peripheral blood T -ce ll 
subpopu latio J1 s (CD4 + ICD7 + and CD8 + ) including the putati ve 
malignant clone f.·o m the CTCL patients (CD4 +ICD7- ) (40 . 41) 
subseq uent to ExP treatm en t (Fig Sa-e) . Of particular note was the 
observa tio n that the malignan t clone £i'om a Sezary syndl'ome 
patient, as identi fied by a mo noclon al anti-V/320 antibody, was also 
susceptibl e to apoptosis indu ction by Ex P (Fig 5t/) . In contra st, no 
shift ill the m onocyte population (CD:l4 + IC D45 + ) was obse rved, 
suggesting that these cells m ay be mo re resistant to induction of 
apop tosis b y ExP o r PUVA treatm ent (Fig 5.1). 
Phagocytosis ofExP and PUVA-Treated Cells Is Not MHC-
Restricted Previo us investigatio ns have shown that apoptotic 
ce Us und ergo specifi c chan ges including altel'ation of surf."lce car'-
boh ydrates (Morris el al, 1984), and expression ofvitro nectin (Savill 
et a l. 1990) o r phosphatidylserine liga nds (Fadok ct af. 1992a , 
1992b), w hich allow the m to be bo und and phagocytized by 
macropha ges in a no n- MH C restri cted manner (Duvall el (I f, 1985; 
Savill el af, 1993). To determine whethe r the PCT -induced apo-
ptotic ce lls were phagocytized at a ll in creased frequen cy as co m-
pared to untreated cells. 4 - 5 day cul tu res of m o nocyte-derived 
macroph ages were in cubated with ExP- treated o r un treated non-
adherent PBMC. When macrophages were incubated with ExP-
treated PBM C, we o bserved phagocytosis of apoptotic ce lls by the 
majority of m acro phages (two to three apoptotic cells per macro-
phage). Wh eJl untreated PBMC were added to the m acrophage 
cultures . however. phagocytized cells were not observed. T his 
difference was not due to settling ra tes of apoptotic JlCI:5IIS no rmal 
ceUs beca use no rmal ce lls settled within 20 min . Moreover , ExP-
treated 1110nocytes that were cultured for 5 days were also abl e to 
phagocytize apoptotic cells bu t not untl'ea ted cell s (data not 
shown) . T hi s furth e r suggests monocyti c recalcitrance to PCT. 
Electro n mi crograph s of PBM C 24 h post-ExP treatm en t were 
exa.mined for evidence of apoptotic phagocytosis. Several instances 
of phagocytosis of apo ptotic cells and probable apoptotic 'blebs' 
were identified (Fig 6) , further suppo rting the o bservation of 
phagocytosis of PCT-treated cells. 
D ISCUSSIO N 
In this study we ha ve dem onstnlted thdt PCT is a potent indu cer of 
apoptosis in PBL. Whereas this was accompli shed by u tilizin g 
several methodologies , the m ost sensitive and obj ective m eans of 
detenninin g apoptotic ce lls was Aow cycom etry. T his approa ch 
offers impo rtant advantages for the stud y of apoptosis in that it C;ln 
relidbly and accurately quantify apopcosis aJld ca n also be combined 
w ith labeli ng o f slIrf."lce antigens in order to identi fy specific cell 
subpopulations in a heterogeneous population. Several investiga-
tors ha ve o bserved this characteris tic "apoptotic shift" of cells £i'om 
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Figure 5. F low cytom etric analysis of apoptosis in lymphocyte 
subpopulations and 1110nocytes. pU MC fro m Sezary Syndromc patien ts 
'were sta ined 'with specifi c Au ofochro lTIc-l abclcd 1l1 0 11 0clona i :uu"jbodics :lIld 
thclI gated fo r the positive ly stailling popu latio n . T hc lop 1'11111'1 oreach gro llp 
rep resents the prc-trcatrnc ll t cells: b(l ( lo1/l I'flflcl represe1lts dlC ce ll s 24 h after 
PC T . R.I and 11..2 gates arc idenrical I'or each group . In cilch gro up except f. 
a cha racteristic apo ptoric shifi: is o hserved. /I) CD~+ /CD7 + ce ll s. b) 
CD4 + /C D7- ce ll s. c) C D·I-/CD7 + ce ll s. d) V{320 + ce lls (c1onc from 
Seza ry Syndrol1le patient) c) CDS + cells. J} C D 14 + cdls: no sh ift ill the 
po pulation is o bserved (Iytllphocytc gates arc included for cClI11pa rison). 
Da ta presented are rcpreseJlJ:a tivc of that o btaill ed fro m five subjects. 
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Figure 6. E lectron microscopy of phagocytosis of PUV A-treated PBMC. Ve nous bl ood was co llected fro m Sczary synd ro me patien ts and treated 
w ith PUV A. PBMC we re isolated and visuali zed by EM. n) Phagocytosis of an apoptotic lymphocyte by pe ri phera l blood mo nocyte. Arrows indicate probab le 
apo pto tic ' blebs' (sralc 11(1 1', 1 J1.1l1). II) Apoptotic lymphocyte complete ly engul fed by peripheral blood m onocyte. N = mo nocyte nucleus, p = phagocyti zed 
apo ptotic lymphocyte (scnl" bnf, 1 J1.1ll ) . c) Phagocytosis of probable apoptotic ' bleb' (--->; senlc bnr, 1 J1.111). 
re latively high FSC/low SSC to low FSC/hi gh SSC in apo ptotic 
th ym ocytes and selected hum an -de rived cell lin es (Swat CI ai, 199 1; 
Darzyn k iew icz cl ai, 1.992; D ive cl ai, 1992; Huschtscha ci ai , 1994). 
To con fi rm that the "shi fted" population of cell s w ere tru ly 
apoptotic and not mere ly cell de bris or necro ti c cells, an adaptation 
of the TUN E L assay for Row cytometl'y was used. T his method is 
based o n Ruo rescent-labeLin g of DNA strand brea ks that arc 
associated with apoptos is. Usi ng ba ck-ga ting ana lys is, we co n-
fi rm ed that the popu latio n of ce ll s w ith the hi ghest Ruorescence, 
i.e" 11100'e D NA strand brea ks, was also the sam e popu);lti on of ceUs 
that had "shifted" d ue to a low FSC/hi gh SSC alteration . Becau se 
DNA fi-agm entation is o ften an earl y event in apoptos is, thi s assay 
appea rs to be a Ill ore sensitive earl y indicato r of apoptosis as 
compared to morphologic changes (Gorczyca Ci ai, 1994) . T hi s was 
evident in our compa risons o f Row cyto metry , electron mi cros-
copy, and Ru orescen t mi croscopy. 
W hereas previous studies have indicated th at DNA damage as a 
result of 8-MOP and UVA trea tmen t leads to cell death (Gasparro 
ef ai , 1989; Marks and Fox, 1991), this study establishes that the 
minimum concentrations of 8-M OP and UVA necessary to indu ce 
apoptosis in PBL from patien t and no rm al volun tee rs is well wi thin 
the range deli vered during ExP. Generatio n of a dose-response 
curve showed that the minimum combination of UV A and 8-MOP 
tha t was necessary to indu ce greater than background le vel s of 
apoptosis wi thin 24 h of treatmen t was 1 .0 J UV A per cm 2 and 50 
ng 8-M O P per ml. W e pre vio usly showed that ce ll d ivision of T 
ce ll s can almost be co mpletely blocked by 1 J UVA per cm 2 in the 
presence of 50 ng 8-MOP per ml (Gasparro el ai, 1989), Moreover, 
thcse data are consisten t with clinical o bservations that pa tien t 
pl asm a levels of 8-MO P mu st exceed 50 ng per 1111 during the 
pe ri od of UVA irnl diatio n (l.0-2 .0 J per cm 2 ) in ord er to exer t a 
therapeutic effect (Wagner cI ai , 1. 979; Edelson e ( ai , 1987). 
O ne of th e most striking observations was that U VA alon e at 
doses 2: 2 J per cm 2 , but not 8-MO P alon e (0-300 ng per ml) , 
induced signifi can t apoptos is in the PBL within 24 - 48 h . Whe reas 
the percentage of apoptotic PBL induced b y UV A alo ne was no t as 
great as that of 8-MOP and UV A in combinatio n , thi s observation 
m ay h<lve 11Iajo r ramifI cations regardin g the ro le o f sunli ght in the 
induction of apoptosis in cutaneo usly trafti ckin g PBL. Sunli ght is 
the most commo n so urce of UV exposure; however, UV C rays do 
not reach the ea rth and UVB represe nts o nl y a minor compo nen t 
w ith UVA presen t at 100-fold levels over UVB, Although UV A is 
1000 times less e ffe c ti ve ill inducin g erythe ma, w hich can o cc ur in 
pro longed e xpos ure, the maj ori ty of sunscreens do not block it. T he 
observati on th 'lt exposure of lymphocytes to a sin gle, lo w dose o f 
UV A (2: 2 .0 J per cm 2 ) resu lts in apoptosis might suggest that 
sunlig ht, o r other UV A exposure such as that inc urred in tann ing 
booths, cou ld destroy cutan eous infil tra ting lymp hocytes , T hi s is 
particularly releva nt given that approx ima te ly 20'1., of UV A ca n 
penetrate to th e level of th e dermal vasculatu re (Everett el ai, 1966), 
and that an indi vidual rece ives approximately 16 J UV A pe r em:! 
with a 1-h summer sun e xposure in Philadelphia. UV A-induction of 
apoptos is in lymphocytes m ay be of bene fit in condi tions such as 
p soriasis; however, it could be deleterio us in other situ ations such 
as wh en the lymph ocytes arc traffi ckin g ill response to an infectious 
agent. Fu rtherm ol'c, if low doses of UVA can induce apoptosis in a 
po pulatiou oflymphocytes v ia DN A dam age and in asmuch as it h as 
demonstrated abili ty to causc mu tagenesis (Gasparro c( ai, 1993) , it 
is likely that UVA can al so ha ve mutagenic e fFects on lymphocytes. 
T his m ay rcpresen t a possibl e means of triggering certain types of 
le ukemias o r lym pho ma s. Altho ugh no direct evidence for this 
ex ists, several epidelTliologic studi es suggest th at there is a link 
between the develo pm ent of non-H od gkin 's lymphoma (Nl-IL) and 
UV cxposure (Fisher , 1994; Stewart, 1994; Stellar, 1995) . M ost 
recently , Adami and colleagues examined the possibili ty of a link 
between UV li ght and non-Hodgkin 's lympho ma (NHL) (includ_ 
ing chro ni c lymph ocyti c leukemi a) by using skin cancer (melanoma 
or squamou s cell carcinoma) as su rrogate markers for UV exposu re. 
In surveying mo re than 110,000 Danish and Swedish individuals 
with eith er NHL o r skin can cer , a strong association between NHL 
and skin can cer, particul arly squamous ce ll carcinoma, was ob-
served (Fisher , 1994) . 
Of parti cular impo rta nce to th e treatment ofSezary syndrome by 
ExP was wheth er the malignan t clone was difFe ren tiall y affected, 
i.e" became apopto tic, as compared to other lymph ocytic popula-
tions . Using immuno phe l1 otyping and flow cytometry, we fOUIld 
that there was no differen ce in the susceptibility of the dltferel\t 
T -cell subpopuiatio ns (C D4 + ICD7 + and C D8+ ) to apoptosis 
fo ll owi ng l'CT treatm ent. Mo re impo rtantl y, these data show that 
th e malignan t clo ne found in the periphera l blood of Sezary 
syndrom e patients undergoes apoptosis at a ra te similar to the othe~ 
subpo pulations subsequent to peT treatment. T his may have 
impo rtan t clinical implications. Sezary syndro m e patients treated 
with ExP maintain the ir absolute number of no rm al T cells wi.th a 
di spropo rtionately greater decrease in the ir total body burden of 
malignant ce ll s (Edelson el ai, 1987) . T hese data indicate th aI 
although the normal T ceUs und ergo apoptos is as a result of ExP, 
they arc qui ckJy replaced by ne w T cells at a rate that is substantiaUy 
g reater than the rate at w hich malig na nt cells mig ra te to th~ 
peripheral b lood . In this regard , w e have p revio usly shown that ill 
sOlli e Seza ry syndro me patients the malignallt clone disappean 
co mpl ete ly fro m the periph eral blood ill respo nse to ExP therapy 
(Rook c/ ai, 199'\ , 1993) . T his suggests tha t apoptosis m ay be all 
essen tial pathway by which ExP m ed iates its clinica l efticacy. 
Because Ex t> trea ts only 2-5'1., o f the tota l body Iymphocytf 
po pulatio n (Lee and Ga rro , 1989), this ma y explain why it is often 
necessary for patients to unde rgo many rounds of therapy to 
achieve a clini cal respo nse, Moreo ver , we ha ve o bserved that in 
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order for ExP to be cl inica ll y effective in CTCL. ;1 m ali gnant c lon e 
must be presen t in the periph eral blood (Rook and Vowels, 
unpublish ed o bservation s) . 
An importan t aspect of apoptos is is that cells undergo in g this 
phenomenon are recognized by phagocytes and taken up before the 
release of intracellula r con tents , protectin g the surro unding tissue 
fro m poten tial t iss ue d amage (Co hcn and D uke, 1992) . In o ur 
investigatio ns, 111 0 nocytes appeared to be I'esistan t to apoptosis. as 
d efi ned by cc llula r ligh t scattering properti cs by fl ow cytom e try and 
flu orescen t microscopy , subscquen t to PCT treatment. Further-
more, Ex P-treated , as well as untreated, m o nocyrcs that were 
c ultured for 5 days were abl e to recogn ize and ph agocytize 
ExP-induced apo ptoti c P13L, suggesting no altcJ':ltio ns in monocyte 
function. T hi s res istan ce to apoptosis m ay be due to the in creased 
e laboratio n of GM-CSF by Ex P-treated mon ocytes (Vowels and 
Rook, unpubli sh ed observatio ns). because GM-CSF h as been 
demonstrated to inhibit apoptosis of hu man Ill onocytes (Strasser el 
ai, 1994). One hypothes is 0 11 the mechanism fo r th e clinica l efficacy 
of ExP is tha t an anti gen assoc iated w ith the ma li gnant clona l 
pop ul ation. poss ibl y the unique T-cell recepto r, is alte red as a res ul t 
of Ex P such that an illlmun e respo nse can be specifi c;llIy generated 
to remove the malign ant clon e ti'o lll the body. Such a scen al'io 
would require an tigen up take . processing, and presentati on and 
c ou ld be en h anced as a resu lt of ma crophage up take of apoptotic 
cell s. 
An altern ative hypothesis to the gen erati on o f clone-specifi c 
immunity is that Ex P m ay resu lt in the ce llular e laboratio n of 
apoptos is-ind ucing f., ctor w hich would be capa bl e of causin g 
apoptos is in ce ll s not treated by Ex P. In this rega rd . tumo r necrosis 
facto r-;1 lpha (TN F-u) has been de lll o nstra ted to indu ce apoptos is in 
ce rtain cell types in clu d in g tum o r ce ll lin es (\l(Iong and Goedde l. 
1994). O ur prev io us studies ha ve delll o nstrated that sig nifi cant 
a mo un ts of T NF-a arc produced h y mon ocytes fo ll o wing Ex P. 
w hich also suggests that 1Il0n ocytes arc resista n t to apo ptosis 
ind uction b y PUV A (Vowe ls ('I al. 199 1). T he o bservatio n that 
TNF can in duce apopcosis suggests a possible physio logic ro le to r 
th e e labo ration of this cytok in e in the therapeutic effectiveness of 
Ex P. 
As these va rio us hypotheses arc tested or as new hypotheses arc 
fo rmul ated , it w ill be important to keep in mind that nearl y all PBL 
treated w itb Ex P will undergo apoptosis and as such ca nnot act in 
an effector fas hio n . Morph o logic chan ges associa ted with apoptosis 
are not appa ren t un til <lpprox illla tely 12 h post-treatJll ent. bu t the 
e x press io n o f ligands necessa ry to r recogni tio n by phagocytes m ay 
occur ea rlie r. As a resul t, PBL treated by ExP woul d be removed 
from the c irculatio n soon afte r re infil sio n . In this reg;l rd , attemp ts 
to identi fy apo ptoti c ce ll s in th e peripheral b lood of patien ts at 
v a ri o us timepo in ts ('I, G. and 24 h) afte r rein fusio n of ExP-treated 
PB M C were unito rml y unsu ccessful (Vowels 1'1 ai, unpublished 
observati o ns). 
Altho ugh we ha ve described the indu ction of apoptos is by PCT. 
it rem ain s unkn own how PCT in duces apoptos is. Studies by M<lrks 
and Fox have shown that PUV A in creases Ca 2 I uptake and po ly 
(ADP-ribose) syn thetase activity and that a prote in syn thes is inhib-
ito r, cyclohexam ide, can decrease the in cidence of PUV A- indu ced 
apoptosis in T -ce ll lin es (M<lrks cl ai, .1 990; Marks and Fox , 199 1) . 
O ur observatio n that induction o t' apoptos is by PUVA is titratable 
suggests tha t additio n al t;lctors such as sta ge of ce ll cycle o r 
e:>.-press ion of specifi c recepto rs . such as CD95 . ma y be impo rtant 
determinants in w hethe r a cell en te rs th e apoptotic pathway. 
Apoptosis inductio n by UV C and UV13 rad ia tion is accompanied by 
a signifi ca nt upregul atio Jl of the tUl1I o r suppresso r gene, p53. a 
find ing we have recentl y dem onstrated ill lymphocytes fi'oll1 pa-
tients treated w ith Ex P (Gasparro aJld Vowe ls. m;lIlu scl'ipt in 
preparatio n). W hether p53, in e ithe r w ild type o r mutant torm. 
plays a ro le in apoptosis inductio n by UV A o r PUV A rcmains to be 
determined . 
ANTI·TUMOR EFFECTS O F S·MOP AND UVA 241 
J 1,/(' dedie(1(f' 'ltis 111rlf1l1scrijJf to tlte 1II(' IIICIJ"}, C!r filiI' sco;a,. alIT/lOr, Dr. B el!inmill R ... 
Vo wels, wl",.'<' slIIidw alld 1I1I1;1IIr/), dl'ath has 1':li liS 1II;lh h;s le<~af)' {)F ('((lhIlS;(/SIil 
In,. dis(OII('ry. dedira/iott [0 scienct', ntffl/o )'n/t )' to his (j) lIcnJ:lIes. 1'1/(, a/so t!tauk Dr. 
JI)J]IIi IVlc)mT, Dr. Flo )'d FClX, Halik Pln r/t e]", Ril)' DO II.{! l nsJ (lIui D Ollll n T-ra z icr.f"r 
f"c/mirnl nSSiSf(HI( (, flIut Itdly ,,1 disCll s.\' '-" "S ",i,/' .fl{l " , ( )'IOII/ crl)'. 
This ,/lo,./':' II '(IS .... HpPol1t'd bJ' l\ fnr;oflnl 111.\'(;",1(· .... (!F H enlth Trnillill,v. Grnlll C.4 -1 
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A .H.R.). 
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